Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Director comp.
|
|
Assertio Therapeutics, Inc (ASRT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2020 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 15,834 shares
@ $0.7914, valued at
$12.5k
|
|
| 04/03/2020 |
4/A
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 7,433 shares
@ $0.6467, valued at
$4.8k
Exercised 25,370 restricted stock units
@ $0 |
|
| 04/03/2020 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 7,433 shares
@ $0
Exercised 25,370 restricted stock units
@ $0 |
|
| 03/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Mason Heather L (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Exercised 14,394 restricted stock units
@ $0 |
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 31,008 shares
@ $1.35, valued at
$41.9k
Exercised 97,412 restricted stock units
@ $0 |
|
| 02/12/2020 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 9,545 shares
@ $1.35, valued at
$12.9k
Exercised 27,588 restricted stock units
@ $0 |
|
| 02/06/2020 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 2,318 shares
@ $1.04, valued at
$2.4k
Granted 371,622 restricted stock units
@ $0
Exercised 6,700 restricted stock units
@ $0 |
|
| 02/06/2020 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 21,590 shares
@ $1.04, valued at
$22.5k
Granted 1,037,838 restricted stock units
@ $0
Exercised 62,399 restricted stock units
@ $0 |
|
| 02/06/2020 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 326,577 restricted stock units
@ $0 |
|
| 12/02/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 2,449 shares
@ $0.76, valued at
$1.9k
Exercised 8,359 restricted stock units
@ $0 |
|
| 12/02/2019 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 10,213 shares
@ $0.76, valued at
$7.8k
Exercised 34,860 restricted stock units
@ $0 |
|
| 11/12/2019 |
4
| STAPLE PETER D (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 13,900 shares
@ $0.713, valued at
$9.9k
|
|
| 11/12/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 10,000 shares
@ $0.7259, valued at
$7.3k
|
|
| 11/12/2019 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 25,000 shares
@ $0.73, valued at
$18.3k
|
|
| 10/01/2019 |
4
| Wheadon David E. (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 145,038 options to buy
@ $0 |
|
| 10/01/2019 |
3
| Wheadon David E. (Director) has filed a Form 3 on Assertio Therapeutics, Inc |
| 09/20/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 3,405 shares
@ $1.33, valued at
$4.5k
Exercised 11,623 restricted stock units
@ $0 |
|
| 08/20/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 10,000 shares
@ $1.52, valued at
$15.2k
Bought 4,000 shares
@ $1.45, valued at
$5.8k
|
|
| 08/20/2019 |
4/A
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 2,900 shares
@ $1.54, valued at
$4.5k
Bought 17,100 shares
@ $1.57, valued at
$26.8k
|
|
| 08/20/2019 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 25,000 shares
@ $1.6097, valued at
$40.2k
|
|
| 08/15/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 515 shares
@ $1.61, valued at
$829.2
Exercised 1,814 restricted stock units
@ $0 |
|
| 08/14/2019 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 4,000 shares
@ $1.557, valued at
$6.2k
|
|
| 08/12/2019 |
4
| Peisert Daniel A. (SVP and CFO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 1,900 shares
@ $1.54, valued at
$2.9k
Bought 17,100 shares
@ $1.57, valued at
$26.8k
|
|
| 08/12/2019 |
4
| HIGGINS ARTHUR J (Director, President and CEO) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Bought 50,000 shares
@ $1.538, valued at
$76.9k
|
|
| 06/14/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 12,500 shares
@ $3.1835, valued at
$39.8k
|
|
| 05/09/2019 |
4
| MCKEE WILLIAM (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 12,500 shares
@ $4.6959, valued at
$58.7k
|
|
| 05/09/2019 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
| 05/09/2019 |
4
| STAPLE PETER D (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
| 05/09/2019 |
4
| MCKEE WILLIAM (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
| 05/09/2019 |
4
| LAVIGNE LOUIS J JR (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Exercised 31,250 restricted stock units
@ $0 |
|
| 05/09/2019 |
4
| FOGARTY JAMES P (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
| 05/09/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
|
|
|